Fri, Feb 27, 2015, 4:51 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

DexCom, Inc. (DXCM) Message Board

  • fly_my_brave_stallion fly_my_brave_stallion Feb 28, 2009 4:50 PM Flag

    Abbott Diabetes Care/Dexcom Patent Litigation

    The Prospectus Supplement, dated January 30, 2009 contains a very deatailed discussion of the 3 1/2 year patent dispute issues. So far, Abbott Diabetes Care has repeatedly struck out. If Dexcom is successful in obtaining a final rejection of Abbott's claims, this stock is going to explode higher like a rocket. The overhang from this litigation has to be in the neighborhood of $2-$3 a share.

    Although not final, this sure sounds encouraging:

    "In early 2008, the Patent Office issued a non-final rejection of all claims we have submitted for reexamination in the other two patents cited in the original complaint." -from the Prospectus Filing

    SortNewest  |  Oldest  |  Most Replied Expand all replies
60.74-1.22(-1.97%)4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.